Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
33%
OVERLAP
BY WEIGHT
21
# OF OVERLAPPING
HOLDINGS
PBE
33
HOLDINGS
72%
ALSO IN BBP
BBP
68
HOLDINGS
35%
ALSO IN PBE
SECTOR DRIFT (PBE minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
| MODERNA, INC. | 3.7% | 5.8% | 3.7% | |
| HALOZYME THERAPEUTICS INC | 3.1% | 2.4% | 2.4% | |
| REGENERON PHARMACEUTICALS | 5.4% | 2.0% | 2.0% | |
| GILEAD SCIENCES INC | 5.5% | 1.8% | 1.8% | |
| PROTAGONIST THERAPEUTICS, INC. | 2.5% | 1.7% | 1.7% | |
PBE Overweight Relative to BBP
| NATERA INC | 5.9% | |
| ROYALTY PHARMA PLC CLASS A | 5.2% | |
| ILLUMINA INC | 5.1% | |
| BIOGEN IDEC INC | 3.9% | |
| GILEAD SCIENCES INC | 3.8% | |
| REGENERON PHARMACEUTICALS | 3.4% | |
| AMGEN INC | 3.4% | |
| VERTEX PHARMACEUTICALS INC | 3.2% | |
| VERACYTE INC | 3.0% | |
| REPLIGEN CORP | 2.6% |
PBE Underweight Relative to BBP
| OMEROS CORP | -2.7% | |
| IOVANCE BIOTHERAPEUTICS INC | -2.7% | |
| MODERNA, INC. | -2.1% | |
| XERIS PHARMACEUTICALS INC | -2.0% | |
| INTREXON CORP | -2.0% | |
| BEIGENE LTD. SPONSORED ADR | -1.8% | |
| ADMA BIOLOGICS, INC. | -1.8% | |
| ARCUTIS BIOTHERAPEUTICS INC | -1.7% | |
| ZAI LAB LTD. UNSPONSORED ADR | -1.7% | |
| LIGAND PHARMACEUTICALS-CL B | -1.6% |